Results 231 to 240 of about 204,221 (349)

2012 Canadian Association of Gastroenterology Educational Needs Assessment Report

Canadian Journal of Gastroenterology, 2012
Craig Render
doaj   +1 more source

CAG News Page [PDF]

Canadian Journal of Gastroenterology, 2011
openaire   +3 more sources

Protocol for optimizing the utilization rates of coronary angiography in Norway. [PDF]

Res Health Serv Reg
Kristensen A, Herder M, Aune E, Forsdahl SH, Haugstvedt JO, Iqbal A, Kolnes K, Leiknes JB, Parkar AP, Rotevatn S, Thoresen C, Wiseth R, Tjomsland O.   +12 more
europepmc   +1 more source

CAG-TOISTOJAKSOJEN SOMAATTISEN LAAJENTUMISEN MERKITYS HUNTINGTONIN TAUDISSA

Huntingtonin tauti on aivoja rappeuttava, kuolettava sairaus. Sairaus johtuu kromosomin neljä HTT-geenissä olevasta poikkeuksellisen suuresta määrästä CAG-toistoja.
Huttunen, Alexandra
core  

Single‐Cell Transcriptomics and Deep Learning Link N‐(2‐Furoyl) Glycine to GLRX3 in Gastric Cancer

Med Research, EarlyView.
ABSTRACT Gastric cancer remains a health burden, and its metabolic drivers are poorly defined. N‐(2‐furoyl) glycine, a circulating metabolite, has been implicated in tumor biology. We investigated its causal role in gastric cancer and the underlying mechanism.
Yingyi Zhang, Chenchen Wang, Tianliang Liu, Ziliang Wang, Zhe Zhang   +4 more
wiley   +1 more source

CAG Research Committee Report: Consolidating and Expanding

Canadian Journal of Gastroenterology, 2005
Derek Mckay
doaj   +1 more source

Coronary angiography findings in emergency department chest pain patients undergoing angiography despite hs-cTnT-based early rule-out angiography after hs-cTnT rule-out in ED chest pain. [PDF]

Open Heart
Avlac A, Altınbilek E, Sönmez BM, Öztürk D, Civelek İ, Çelik S.   +5 more
europepmc   +1 more source

Systematic Review of the Huntington's Disease Drug Development Pipeline, 2014 to 2025

Movement Disorders, EarlyView.
Abstract Background In the past decade, significant advances have improved our understanding of the mechanisms underlying HD pathobiology leading to several putative therapeutic targets for HD. Objective The aim was to describe the Huntington's disease (HD) drug development clinical pipeline.
Pavlina Konstantinova, Jenny Townhill, Juliana Bronzova, Viktoria Andreeva, Swati Sathe, Cristina Sampaio   +5 more
wiley   +1 more source

2004 CAG Educational Needs Assessment Report

Canadian Journal of Gastroenterology, 2005
Ronald Bridges
doaj   +1 more source

Short CAG repeat variation as a regulatory factor in health and disease. [PDF]

Front Genet
Manjarrez JR.
europepmc   +1 more source